EPISODE · Jan 1, 2025 · 12 MIN
2024 Year in Review — Part 2
from Eyewire News: The Podcast · host Eyewire News
In today’s episode, we review the top stories from the second half of 2024. The last six months saw the launch of first-of-its-kind IOLS; the clinical advancement of gene therapies for rare diseases; the FDA approval of a device to treat patients with dry AMD; and introduction of novel OCTA technology. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
2024 Year in Review — Part 2
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m